Antibiotic stewardship ward rounds and a dedicated prescription chart reduce antibiotic consumption and pharmacy costs without affecting inpatient mortality or re-admission rates

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Boyles, Tom H ^a   Whitelaw, Andrew ^a,b,c   Bamford, Colleen ^a,b   Moodley, Mischka ^a,b   Bonorchis, Kim ^a,b   Morris, Vida ^a   Rawoot, Naazneen ^a   Naicker, Vanishree ^a   Lusakiewicz, Irena ^a   Black, John ^a   Stead, David ^a   Lesosky, Maia ^b   Raubenheimer, Peter ^a   Dlamini, Sipho ^a   Mendelson, Marc ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC STEWARDSHIP WARD ROUND; ARTICLE; CONTROLLED STUDY; DEVELOPING COUNTRY; DRUG COST; HOSPITAL PATIENT; HOSPITAL PHARMACY; HOSPITAL READMISSION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PRESCRIPTION; SOUTH AFRICA; TEACHING HOSPITAL; TEACHING ROUND; WARD;

ANTI-BACTERIAL AGENTS; DRUG UTILIZATION; HOSPITALS; HUMANS; INPATIENTS;

EID: 84892593499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079747     Document Type: Article

References (25)

1. World Health Organization Urgent action needed to safeguard drug treatments. Available: http://www.who.int/mediacentre/news/releases/2011/whd- 20110406/en. Accessed 9th May 2013.
2. Nordmann P, Dortet L, Poirel L (2012) Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 18: 263-272. doi:10.1016/j.molmed.2012.03.003. PubMed: 22480775.
3. Woodford N, Livermore DM (2009) Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect 59 Suppl: 4-16. doi: 10.1016/S0163-4453(09)60003-7. PubMed: 19766888.
4. Bamford C, Bonorchis K, Elliott E, Hoffmann R, Ismail N et al. (2011) Antimicrobial susceptibility patterns of selected bacteraemic isolates from South Africa public sector hospitals, 2010. South Afr J Epidemiol Infect 26: 243-250.
5. Brink A, Coetzee J, Clay CG, Corcoran C, van Greune J et al. (2012) The spread of carbapenem-resistant Enterobacteriaceae (CRE) in South Africa: Risk factors for acquisition and prevention. S Afr Med J 102: 599-601. PubMed: 22748433.
6. Brink AJ, Coetzee J, Clay CG, Sithole S, Richards GA et al. (2012) Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J Clin Microbiol 50: 525-527. doi:10.1128/JCM.05956-11. PubMed: 22116157.
7. Visser A, Moore DP, Whitelaw A, Lowman W, Kantor G et al. (2011) Global Antibiotic Resistance Partnership Situation Analysis: Antibiotic use and resistance in South Africa Part VII. Interventions. S Afr Med J 101: 587-595. PubMed: 21920138.
8. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL et al. (1997) Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25: 584-599. doi: 10.1086/513766. PubMed: 9314444.
9. Lepper PM, Grusa E, Reichl H, Högel J, Trautmann M (2002) Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 46: 2920-2925. doi:10.1128/AAC.46.9. 2920-2925.2002. PubMed: 12183248.
10. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA et al. (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44: 159-177. doi:10.1086/510393. PubMed: 17173212.
11. Paruk F, Richards G, Scribante J, Bhagwanjee S, Mer M et al. (2012) Antibiotic prescription practices and their relationship to outcome in South African intensive care units: Findings of the Prevalence of Infection in South Africa Intensive Care Units (PISA) study. S Afr Med J 102: 613-616. PubMed: 22748439.
12. Hoffman D, Botha J, Kleinschmidt I (2003) An assessment of factors influencing the prescribing of antibiotics in Acute Respiratory Illness: A questionnaire study. SA Fam Pract 45: 20-24.
13. Davey P, Brown E, Charani E, Fenelon L, Gould IM et al. (2013) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev Issue 4. Art. No.: CD003543. PubMed: 2363331316235326.
14. th May 2013.
15. th June 2013.
16. Ramsay C, Brown E, Hartman G, Davey P (2003) Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 52: 764-771. doi:10.1093/jac/dkg460. PubMed: 14563901.
17. Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr et al. (1997) Antibiotic optimization. An evaluation of patient safety and economic impact. Arch Intern Med 157: 1689-1694. doi:10.1001/archinte.157.15.1689. PubMed: 9250230.
18. Carling P, Fung T, Killion A, Terrin N, Barza M (2003) Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 24: 699-706. doi: 10.1086/502278. PubMed: 14510254.
19. LaRocco A Jr (2003) Concurrent antibiotic review programs - a role for infectious diseases specialists at small community hospitals. Clin Infect Dis 37: 742-743. doi:10.1086/377286. PubMed: 12942418.
20. Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA et al. (2001) Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 33: 289-295. doi: 10.1086/321880. PubMed: 11438891.
21. Durbin WA Jr, Lapidas B, Goldmann DA (1981) Improved antibiotic usage following introduction of a novel prescription system. JAMA 246: 1796-1798. doi:10.1001/jama.1981.03320160028024. PubMed: 7277668.
22. Echols RM, Kowalsky SF (1984) The use of an antibiotic order form for antibiotic utilization review: influence on physicians' prescribing patterns. J Infect Dis 150: 803-807. doi:10.1093/infdis/150.6.803. PubMed: 6501926.
23. Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 177: 498-505. doi: 10.1164/rccm.200708-1238OC. PubMed: 18096708.
24. Scoeder S, Hochreiter M, Koehler T, Schweiger AM, Bein B et al. (2009) Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 394: 221-226. doi:10.1007/s00423-008- 0432-1. PubMed: 19034493.
25. th May 2013.